ES2132233T3 - Composiciones de vacunas a base de virus respiratorio sincicial atenuado. - Google Patents
Composiciones de vacunas a base de virus respiratorio sincicial atenuado.Info
- Publication number
- ES2132233T3 ES2132233T3 ES93912315T ES93912315T ES2132233T3 ES 2132233 T3 ES2132233 T3 ES 2132233T3 ES 93912315 T ES93912315 T ES 93912315T ES 93912315 T ES93912315 T ES 93912315T ES 2132233 T3 ES2132233 T3 ES 2132233T3
- Authority
- ES
- Spain
- Prior art keywords
- attenuated
- virus
- rsv
- vaccine compositions
- compositions based
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Vertical, Hearth, Or Arc Furnaces (AREA)
Abstract
EN LA PRESENTE INVENCION SE PRESENTAN COMPOSICIONES PARA VACUNAS DE VIRUS SINCITIALES RESPIRATORIOS ATENUADOS (RSV). EN PARTICULAR LOS VIRUS ATENUADOS SE PUEDEN DERIVAR DE UN RSV QUE HAYA SIDO ATENUADO DE FORMA INCOMPLETA MEDIANTE EL PASO EN FRIO O INTRODUCCION DE MUTACIONES QUE PRODUCEN VIRUS QUE TIENEN UN FENOTIPO SENSIBLE A LA TEMPERATURA (TS) O ADAPTADO AL FRIO (CA). EN LA INVENCION TAMBIEN SE PRESENTAN LOS METODOS PAR ESTIMULAR EL SISTEMA INMUNE DE UN INDIVIDUO PARA INDUCIR UNA PROTECCION CONTRA LOS VIRUS SINCITIALES RESPIRATORIOS MEDIANTE LA ADMINISTRACION DE LOS RSV ATENUADOS. EN LA INVENCION TAMBIEN SE PRESENTAN CULTIVOS PUROS DE VIRUS RS ATENUADOS, EN DONDE EL VIRUS SE HA ATENUADO DE FORMA MAS COMPLETA MEDIANTE LA DERIVACION ADICIONAL DE LOS MUTANTES TS O CP ATENUADOS DE FORMA INCOMPLETA PREVIAMENTE IDENTIFICADOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87274692A | 1992-04-21 | 1992-04-21 | |
US3994593A | 1993-04-09 | 1993-04-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2132233T3 true ES2132233T3 (es) | 1999-08-16 |
Family
ID=26716607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93912315T Expired - Lifetime ES2132233T3 (es) | 1992-04-21 | 1993-04-20 | Composiciones de vacunas a base de virus respiratorio sincicial atenuado. |
Country Status (18)
Country | Link |
---|---|
US (3) | US5922326A (es) |
EP (1) | EP0640128B1 (es) |
JP (1) | JP3883202B2 (es) |
KR (1) | KR100257171B1 (es) |
AT (1) | ATE181359T1 (es) |
AU (1) | AU683840B2 (es) |
CA (1) | CA2118509C (es) |
DE (1) | DE69325370T2 (es) |
DK (1) | DK0640128T3 (es) |
ES (1) | ES2132233T3 (es) |
GR (1) | GR3031208T3 (es) |
HU (1) | HU220189B (es) |
IL (1) | IL105456A (es) |
MX (1) | MX9302278A (es) |
NZ (1) | NZ252857A (es) |
RU (1) | RU2139729C1 (es) |
UA (1) | UA41315C2 (es) |
WO (1) | WO1993021310A1 (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
TW275632B (es) * | 1992-04-21 | 1996-05-11 | American Cyanamid Co | |
DE69409243T2 (de) | 1993-08-06 | 1998-08-06 | Connaught Lab | Inaktivierte respiratorische synzytial-virus-impfstoffe |
US7223410B1 (en) | 1994-08-05 | 2007-05-29 | Sanofi Pasteur Limited | Inactivated respiratory syncytial viral vaccines |
WO1996010400A1 (en) * | 1994-09-30 | 1996-04-11 | The Uab Research Foundation | Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses |
US5716821A (en) * | 1994-09-30 | 1998-02-10 | Uab Research Foundation | Prevention and treatment of respiratory tract disease |
US6083925A (en) | 1995-06-07 | 2000-07-04 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
US6019980A (en) * | 1995-06-07 | 2000-02-01 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
US7846455B2 (en) | 1996-07-15 | 2010-12-07 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated chimeric respiratory syncytial virus |
US20050287540A1 (en) * | 1995-09-27 | 2005-12-29 | Murphy Brian R | Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences |
US7485440B2 (en) | 1995-09-27 | 2009-02-03 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
JPH11512609A (ja) | 1995-09-27 | 1999-11-02 | アメリカ合衆国 | クローン化されたヌクレオチド配列からの感染性RSウイルス(respiratory syncytial virus)の生産 |
US6689367B1 (en) | 1995-09-27 | 2004-02-10 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
AU2438597A (en) * | 1996-04-04 | 1997-10-29 | Regents Of The University Of Michigan, The | Attenuated respiratory syncytial virus |
US6077514A (en) * | 1996-04-04 | 2000-06-20 | The Regents Of The University Of Michigan | Attenuated respiratory syncytial virus |
ATE234631T1 (de) * | 1996-07-12 | 2003-04-15 | Aventis Pasteur | Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten |
US6699476B1 (en) | 1996-07-15 | 2004-03-02 | Peter L. Collins | Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules |
EP2112220A3 (en) * | 1996-07-15 | 2010-01-06 | The Government of the United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
AU4427897A (en) * | 1996-09-27 | 1998-04-17 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales |
US7201907B1 (en) | 1997-05-23 | 2007-04-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines |
US20030082209A1 (en) | 2000-07-05 | 2003-05-01 | Skiadopoulos Mario H. | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
US6410023B1 (en) | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
US7951383B2 (en) | 1997-05-23 | 2011-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Attenuated parainfluenza virus (PIV) vaccines |
US7632508B2 (en) | 1997-05-23 | 2009-12-15 | The United States Of America | Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
FR2764903A1 (fr) * | 1997-06-23 | 1998-12-24 | Pasteur Institut | Detection des infections par des paramyxovirus (virus respiratoire syncitial et virus parainfluenza) utilisant des polynucleotides codant de la proteine l |
US20040005542A1 (en) | 2001-06-22 | 2004-01-08 | Krempl Christine D | Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes |
US7662397B2 (en) | 1997-07-15 | 2010-02-16 | The United States Of America As Represented By The Department Of Health And Human Services | Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes |
US6177082B1 (en) | 1998-08-13 | 2001-01-23 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6482414B1 (en) | 1998-08-13 | 2002-11-19 | The University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
US6579528B1 (en) | 1998-08-13 | 2003-06-17 | The University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
WO2000061611A2 (en) | 1999-04-13 | 2000-10-19 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
US7820182B2 (en) * | 1999-07-09 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions |
EP1287152B1 (en) | 1999-07-09 | 2008-12-31 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES | Human-bovine chimeric respiratory syncytial virus vaccines |
CA2403979A1 (en) | 2000-04-03 | 2001-10-11 | The University Of Pittsburgh Of The Commonwealth System Of Higher Education | Cold-adapted equine influenza viruses |
KR20040071678A (ko) * | 2001-09-28 | 2004-08-12 | 유니버시티 오브 사우스 플로리다 | Rsv 유전자 발현 백신 |
WO2003091401A2 (en) | 2002-04-26 | 2003-11-06 | Medimmune Vaccines, Inc. | Multi plasmid system for the production of influenza virus |
US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
EP1572108A4 (en) * | 2002-09-27 | 2008-09-17 | Medimmune Vaccines Inc | FUNCTIONAL MUTATIONS OF RSV (RESPIRATORY SYNCYTIAL VIRUS) |
CA2518924C (en) * | 2003-03-18 | 2016-06-07 | Wyeth Holdings Corporation | Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
ATE469170T1 (de) * | 2003-03-28 | 2010-06-15 | Medimmune Llc | Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320 |
WO2005018539A2 (en) | 2003-06-16 | 2005-03-03 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
WO2005058356A2 (en) * | 2003-12-17 | 2005-06-30 | Wyeth | Methods for porducing storage stable viruses and immunogenic compositions thereof |
ES2345492T3 (es) | 2003-12-23 | 2010-09-24 | Medimmune, Llc | Sistema multiplasmido para la produccion del virus de la gripe. |
WO2005116260A2 (en) * | 2004-05-25 | 2005-12-08 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
EP2441471B1 (en) | 2005-03-08 | 2014-10-08 | MedImmune, LLC | Reassortant influenza viruses |
EP2049662A4 (en) * | 2006-07-21 | 2009-12-30 | Medimmune Llc | METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS |
CA2659267C (en) * | 2006-08-09 | 2016-12-13 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
JP5666905B2 (ja) * | 2007-06-18 | 2015-02-12 | メディミューン,エルエルシー | ヘマグルチニンポリペプチド中に変化を有するインフルエンザbウイルス |
EP2069485A4 (en) * | 2007-07-13 | 2011-05-25 | Medimmune Llc | PREPARATION OF NEGATIVE STRAND RNA VIRUSES BY ELECTROPORATION |
SG192501A1 (en) | 2008-07-11 | 2013-08-30 | Medimmune Llc | Influenza hemagglutinin and neuraminidase variants |
WO2010093537A2 (en) * | 2009-02-12 | 2010-08-19 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
GB201003630D0 (en) | 2010-03-04 | 2010-04-21 | Novartis Ag | Avian rotavirus |
SG11201401137TA (en) | 2011-10-07 | 2014-07-30 | Medimmune Llc | Influenza hemagglutinin variants |
EP3875112A1 (en) | 2012-04-13 | 2021-09-08 | The United States of America, as Represented By the Secretary, Department of Health and Human Services | Genetically stable live attenuated respiratory syncytial virus vaccine and its production |
CN105189756B (zh) | 2013-03-14 | 2021-06-11 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
CA2902560A1 (en) * | 2013-03-14 | 2014-09-25 | President And Fellows Of Harvard College | Nanoparticle-based compositions |
US11235050B2 (en) | 2015-10-29 | 2022-02-01 | Emory University | Chimeric RSV, immunogenic compositions, and methods of use |
RU2746280C1 (ru) * | 2020-08-03 | 2021-04-12 | Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр фундаментальной и трансляционной медицины" (ФИЦ ФТМ) | Штамм респираторно-синцитиального вируса RSV/Novosibirsk/66Hl/2018 для использования в диагностике респираторно-синцитиальной вирусной инфекции и исследования эффективности противовирусных препаратов in vitro |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4866034A (en) * | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
US4800078A (en) * | 1987-05-28 | 1989-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunotherapeutic method of treating respiratory disease by intranasal administration of Igb |
US5250298A (en) * | 1988-10-07 | 1993-10-05 | University Of Delaware | Live attenuated newcastle disease virus vaccines and preparation thereof |
-
1993
- 1993-04-19 IL IL10545693A patent/IL105456A/en not_active IP Right Cessation
- 1993-04-20 KR KR1019940703740A patent/KR100257171B1/ko not_active IP Right Cessation
- 1993-04-20 DE DE69325370T patent/DE69325370T2/de not_active Expired - Fee Related
- 1993-04-20 HU HU9403023A patent/HU220189B/hu not_active IP Right Cessation
- 1993-04-20 WO PCT/US1993/003670 patent/WO1993021310A1/en active IP Right Grant
- 1993-04-20 JP JP51866393A patent/JP3883202B2/ja not_active Expired - Fee Related
- 1993-04-20 AU AU42907/93A patent/AU683840B2/en not_active Ceased
- 1993-04-20 EP EP93912315A patent/EP0640128B1/en not_active Expired - Lifetime
- 1993-04-20 CA CA002118509A patent/CA2118509C/en not_active Expired - Fee Related
- 1993-04-20 UA UA94105948A patent/UA41315C2/uk unknown
- 1993-04-20 ES ES93912315T patent/ES2132233T3/es not_active Expired - Lifetime
- 1993-04-20 NZ NZ252857A patent/NZ252857A/en not_active IP Right Cessation
- 1993-04-20 MX MX9302278A patent/MX9302278A/es not_active IP Right Cessation
- 1993-04-20 AT AT93912315T patent/ATE181359T1/de not_active IP Right Cessation
- 1993-04-20 DK DK93912315T patent/DK0640128T3/da active
- 1993-04-20 RU RU94045898A patent/RU2139729C1/ru not_active IP Right Cessation
-
1994
- 1994-10-21 US US08/327,263 patent/US5922326A/en not_active Expired - Lifetime
-
1995
- 1995-05-30 US US08/453,304 patent/US6284254B1/en not_active Expired - Lifetime
- 1995-05-30 US US08/453,294 patent/US5882651A/en not_active Expired - Lifetime
-
1999
- 1999-09-15 GR GR990402303T patent/GR3031208T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH07505891A (ja) | 1995-06-29 |
UA41315C2 (uk) | 2001-09-17 |
KR100257171B1 (ko) | 2000-05-15 |
EP0640128B1 (en) | 1999-06-16 |
RU2139729C1 (ru) | 1999-10-20 |
CA2118509A1 (en) | 1993-10-28 |
AU4290793A (en) | 1993-11-18 |
US5882651A (en) | 1999-03-16 |
MX9302278A (es) | 1994-07-29 |
HUT69992A (en) | 1995-09-28 |
KR950701382A (ko) | 1995-03-23 |
US5922326A (en) | 1999-07-13 |
EP0640128A1 (en) | 1995-03-01 |
DE69325370T2 (de) | 1999-10-14 |
DK0640128T3 (da) | 1999-11-22 |
WO1993021310A1 (en) | 1993-10-28 |
IL105456A0 (en) | 1993-08-18 |
ATE181359T1 (de) | 1999-07-15 |
DE69325370D1 (de) | 1999-07-22 |
NZ252857A (en) | 1997-06-24 |
GR3031208T3 (en) | 1999-12-31 |
HU220189B (hu) | 2001-11-28 |
IL105456A (en) | 1996-12-05 |
US6284254B1 (en) | 2001-09-04 |
HU9403023D0 (en) | 1994-12-28 |
RU94045898A (ru) | 1996-09-20 |
JP3883202B2 (ja) | 2007-02-21 |
AU683840B2 (en) | 1997-11-27 |
CA2118509C (en) | 2009-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132233T3 (es) | Composiciones de vacunas a base de virus respiratorio sincicial atenuado. | |
CA2339089A1 (en) | Cold-adapted equine influenza viruses | |
MA22842A1 (fr) | Procede de preparation de compositions de vaccin. | |
BRPI9710363B8 (pt) | partìcula de vìrus sincicial respirátorio recombinante (rsv) infeccioso atenuado, vacina para induzir proteção contra o vìrus sincicial respiratório recombinante (rsv), vetor de expressão, e, método de produção de um vìrus sincicial respiratório recombinante (rsv) infeccioso. | |
ATE476983T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen der atemwege | |
EE05633B1 (et) | Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine | |
DK0869814T3 (da) | Stabilisatorer til levende vacciner | |
UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
PT692028E (pt) | Farmacos baseados em papilomavirus | |
DK0475528T3 (da) | Tandporcelæn | |
NZ337885A (en) | vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid | |
MX9802285A (es) | Vacunas y glicoproteinas de virus de parainfluenza. | |
ES2182914T3 (es) | Inmunopotenciacion inducida de quitosan. | |
DK0739205T3 (da) | Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner | |
NZ505894A (en) | Methylenebisbenzaldehyde derivatives, methylidynetrisphenol derivative and pharmaceuticals thereof; useful for treating or preventing pneumovirus infection and associated diseases | |
WO2000057909A3 (en) | Attenuated dengue-2 virus vaccine | |
WO2001074386A3 (en) | Cold-adapted equine influenza viruses | |
AU3439799A (en) | Immunization against and treatment for infection by (h.pylori) | |
WO2003049670A3 (en) | Adjuvant formulations for bacterial and virus vaccines and method of making same | |
BR9909076A (pt) | Vìrus atenuado do sarampo, recombinantemente gerado, isolado, vìrus do sarampo, vìrus sincicial respiratório humano (rsv), subgrupo b, atenuado, recombinantemente gerado, isolado, o rsv, subgrupo b, vacina processo para imunização de um indivìduo para induzir proteção contra vìrus do sarampo, processo para imunização de um indivìduo para induzir proteção contra o rsv, subgrupo b, composição, processo para produção de vìrus do sarampo infeccioso atenuado, processo para produção de rsv infeccioso atenuado subgrupo b | |
WO2000012684A3 (en) | Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus | |
HUP9700975A2 (hu) | Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok | |
ES2055610T3 (es) | Vacuna contra hrsv. | |
BR9907885A (pt) | Composição de vacina, processo para fazer surgir uma resposta imune a um antìgeno de vìrus sincicial respiratório, e, composição imunogênica | |
DK0579765T3 (da) | Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 640128 Country of ref document: ES |